Lana Wahid, Joshua Froess, Thomas L Ortel, Ryan Zarychanski, Michelle N Gong, Mary Cushman, Lucy Kornblith, Lana Castellucci, Michael E Farkouh, Ewan Gologher, Bryan J McVerry, Grant V Bochicchio, Abhijit Duggal, Yonatan Greenstein, Nicholas Hanna, Kristin Hudock, David T Huang, Robert Hyzy, Akram Khan, Vidya Krishnan, Matthew Kutcher, George Lim, Jose Luis Lopez-Sendon Moreno, Michael A Matthay, Ambarish Pandey, John Quigley, Lewis Satterwhite, Robert J Widmer, Jenny Jenny Wilson, Judith S Hochman, Jeffrey S Berger, Matthew D Neal, Patrick R Lawler. Abstract 13200: Changes in Thrombi-Inflammatory Biomarkers Associated With Therapeutic Heparin in Non-Critically Ill Patients Hospitalized With COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC Randomized Clinical Trial. Circulation. 2023 Nov 7; 148(Suppl_1):a13200-a13200.
UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Abstract 13200: Changes in Thrombi-Inflammatory Biomarkers Associated With Therapeutic Heparin in Non-Critically Ill Patients Hospitalized With COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC Randomized Clinical Trial.
2023
https://researcherprofiles.org/profile/525012789